老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reviva Pharmaceuticals Holdings, Inc.

0.3600
-0.0250-6.49%
盘后：0.37400.0140+3.89%16:59 EDT
成交量：213.78万
成交额：80.09万
市值：2,448.13万
市盈率：-0.47
高：0.3955
开：0.3955
低：0.3600
收：0.3850
数据加载中...
总览公司新闻资讯公告
2022/02/01

重要事件披露

8-K - Current report
2022/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/26

重要事件披露

8-K - Current report
2021/12/10

重要事件披露

8-K - Current report
2021/11/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/15

重要事件披露

8-K - Current report
2021/09/20

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/06/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/19

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多